40 participants
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2026-06-17
- Completion:
- 2030-04-30
Conditions
- Recurrent Glioblastoma Multiforme(GBM)
Interventions
- BIOLOGICAL
No Results Yet